Ranbaxy Laboratories Overview
- Year Founded
-
1961
- Status
-
Acquired/Merged
- Employees
-
12,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
7
Ranbaxy Laboratories General Information
Description
Manufacturer of pharmaceutical products intended to provide quality and affordable pharmaceuticals. The company manufactures and markets generic, branded generic, value-added and over-the-counter products, antiretrovirals, active pharmaceutical ingredients and intermediates.
Contact Information
Website
www.ranbaxy.comCorporate Office
- Western Edge-I, Unit No. 201-204
- 2nd floor, Western Express Highway, Borivali East
- Mumbai, Maharashtra 400066
- India
Corporate Office
- Western Edge-I, Unit No. 201-204
- 2nd floor, Western Express Highway, Borivali East
- Mumbai, Maharashtra 400066
- India
Ranbaxy Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ranbaxy Laboratories Comparisons
Industry
Financing
Details
Ranbaxy Laboratories Competitors (8)
One of Ranbaxy Laboratories’s 8 competitors is Zydus Lifesciences, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Lupin | Corporation | Mumbai, India | ||||
| Natco Pharma | Corporation | Hyderabad, India | ||||
| Dr. Reddy's | Corporation | Hyderabad, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India |
Ranbaxy Laboratories Patents
Ranbaxy Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170129895-A1 | Amorphous form of baricitinib | Inactive | 28-Mar-2014 | ||
| US-20170056365-A1 | Dapagliflozin compositions | Inactive | 28-Feb-2014 | ||
| US-20170174635-A1 | Process for the preparation of enzalutamide | Inactive | 13-Feb-2014 | ||
| WO-2015121768-A1 | Process for the preparation of enzalutamide | Inactive | 13-Feb-2014 | ||
| WO-2015121769-A1 | Process for the preparation of methyl n-[(benzyloxy)-carbonyl]-l-leucyl-l-phenylalaninate | Inactive | 13-Feb-2014 | C07K5/1016 |
Ranbaxy Laboratories Signals
Ranbaxy Laboratories Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ranbaxy Laboratories Investments & Acquisitions (7)
Ranbaxy Laboratories’s most recent deal was a Merger/Acquisition with Zenotech Laboratories. The deal was made on 01-Jan-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zenotech Laboratories | 01-Jan-2014 | Merger/Acquisition | Pharmaceuticals | ||
| Krebs Biochemicals & Industries | 15-Jan-2007 | PIPE | Pharmaceuticals | ||
| GlaxoSmithKline (Spanish Mundogen Generic Business) | 18-Jul-2006 | Merger/Acquisition | Pharmaceuticals | ||
| Terapia | 08-Jun-2006 | Merger/Acquisition | Pharmaceuticals | ||
| Allen (Generic Business) | 01-Apr-2006 | Merger/Acquisition | Pharmaceuticals |
Ranbaxy Laboratories Exits (2)
Ranbaxy Laboratories’s most recent exit was on 11-Nov-2005 from Nihon Pharmaceutical. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Nihon Pharmaceutical | 11-Nov-2005 | Completed |
|
||
| Nihon Pharmaceutical | 01-Jan-2002 | Secondary Transaction - Private | Completed |
Ranbaxy Laboratories FAQs
-
When was Ranbaxy Laboratories founded?
Ranbaxy Laboratories was founded in 1961.
-
Where is Ranbaxy Laboratories headquartered?
Ranbaxy Laboratories is headquartered in Mumbai, India.
-
What is the size of Ranbaxy Laboratories?
Ranbaxy Laboratories has 12,000 total employees.
-
What industry is Ranbaxy Laboratories in?
Ranbaxy Laboratories’s primary industry is Pharmaceuticals.
-
Is Ranbaxy Laboratories a private or public company?
Ranbaxy Laboratories is a Private company.
-
What is the current valuation of Ranbaxy Laboratories?
The current valuation of Ranbaxy Laboratories is .
-
What is Ranbaxy Laboratories’s current revenue?
The current revenue for Ranbaxy Laboratories is .
-
Who are Ranbaxy Laboratories’s investors?
Daiichi Sankyo has invested in Ranbaxy Laboratories.
-
Who are Ranbaxy Laboratories’s competitors?
Zydus Lifesciences, Lupin, Natco Pharma, Dr. Reddy's, and Glenmark Pharmaceuticals are some of the 8 competitors of Ranbaxy Laboratories.
-
When was Ranbaxy Laboratories acquired?
Ranbaxy Laboratories was acquired on 24-Mar-2015.
-
Who acquired Ranbaxy Laboratories?
Ranbaxy Laboratories was acquired by Sun Pharmaceutical Industries.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process